Tỷ lệ mắc và đặc điểm bệnh nhân của tắc mạch tĩnh mạch trong quá trình hóa trị liệu neoadjuvant cho ung thư buồng trứng

Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41(1):3–14 Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3):529–535 Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160(6):809–815 Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6):715–722 Wun T, White RH (2009) Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 22(1):9–23 Fotopoulou C, duBois A, Karavas AN, Trappe R, Aminossadati B, Schmalfeldt B et al (2008) Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol 26(16):2683–2689 Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25):1846–1850 Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH (2007) Venous thromboembolism in ovarian cancer. Gynecol Oncol 105(3):784–790 Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S–e227S77S Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S et al (2007) High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer 97(8):1053–1057 Salinaro JR, McQuillen K, Stemple M, Boccaccio R, Ehrisman J, Lorenzo AM et al (2020) Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Int J Gynecol Cancer 30(4):491–497 Greco PS, Bazzi AA, McLean K, Reynolds RK, Spencer RJ, Johnston CM et al (2017) Incidence and timing of thromboembolic events in patients with ovarian cancer undergoing neoadjuvant chemotherapy. Obstet Gynecol 129(6):979–985 den Exter PL, Hooijer J, Dekkers OM, Huisman MV (2011) Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 29(17):2405–2409 Rahn DD, Mamik MM, Sanses TV, Matteson KA, Aschkenazi SO, Washington BB et al (2011) Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review. Obstet Gynecol 118(5):1111–1125 White RH, Keenan CR (2009) Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 123(Suppl 4):S11–S17 Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19–24 Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS (2008) Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol 97(2):103–107 Lippi G, Franchini M (2008) Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 34(8):747–761 Committee on Practice Bulletins–Gynecology ACoO, Gynecologists (2007) ACOG Practice Bulletin No. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 110(2 Pt 1):429–440 Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38(5):496–520 Gressel GM, Marcus JZ, Mullen MM, Sinno AK (2021) Direct oral anticoagulant use in gynecologic oncology: a Society of Gynecologic Oncology Clinical Practice Statement. Gynecol Oncol 160(1):312–321 Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902–4907 Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R et al (2010) Prediction of venous thromboembolism in cancer patients. Blood 116(24):5377–5382 Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N et al (2019) The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica 104(6):1277–1287 van Es N, Ventresca M, Di Nisio M, Zhou Q, Noble S, Crowther M et al (2020) The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis. J Thromb Haemost 18(8):1940–1951 Srikanthan A, Tran B, Beausoleil M, Jewett MA, Hamilton RJ, Sturgeon JF et al (2015) Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy. J Clin Oncol 33(6):582–587 Tran B, Ruiz-Morales JM, Gonzalez-Billalabeitia E, Patrikidou A, Amir E, Seidel C et al (2020) Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: a study by the global germ cell cancer group (G3). Cancer Med 9(1):116–124 Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632–634 Barber EL, Clarke-Pearson DL (2017) Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol 144(2):420–427